Pasithea Therapeutics Corp Strategic Asset Allocation Index
Pasithea Therapeutics Corp strategic asset allocation index. Pasithea Therapeutics Corp (KTTA) has a Strategic Asset Allocation Index of 1.7% as of June 2023. Strategic assets (PP&E of $593.18K plus long-term investments of $-) total $593.18K, measured against net assets of $35.59 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Pasithea Therapeutics Corp (KTTA) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Pasithea Therapeutics Corp (2021–2021)
Strategic asset allocation index of Pasithea Therapeutics Corp from 2021 to 2021. This chart shows how Pasithea Therapeutics Corp's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of June 2023, the index stands at 1.7%, representing strategic assets of $593.18K against net assets of $35.59 Million USD. Check Pasithea Therapeutics Corp tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Pasithea Therapeutics Corp Strategic Asset Allocation Index by Year (2021–2021)
Pasithea Therapeutics Corp strategic asset allocation index by year from 2021 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Pasithea Therapeutics Corp from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see KTTA market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.0% | $20.12K | $20.12K | $- | $51.42 Million | — |